Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPCASTRO JR., Gilberto DeTAN, Daniel Shao-WengCRINO, LucioWU, Yi LongPAZ-ARES, LuisWOLF, JuergenGEATER, SarayutORLOV, SergeyCORTINOVIS, DiegoYU, Chong-JenHOCHMAIR, MaximilianCORTOT, AlexisTSAI, Chun-MingMORO-SIBILOT, DenisCAMPELO, Rosario GarciaBRANLE, FabriceSEN, ParamitaMCCULLOCH, TraceySORIA, Jean-Charles2018-02-222018-02-222017JOURNAL OF THORACIC ONCOLOGY, v.12, n.1, suppl.S, p.S7-S7, 20171556-0864https://observatorio.fm.usp.br/handle/OPI/25329engrestrictedAccessCeritinibASCEND-4ALKNSCLCFirst-line Ceritinib Versus Chemotherapy in Patients with ALK-rearranged (ALK plus ) NSCLC: A Randomized, Phase 3 Study (ASCEND-4)conferenceObjectCopyright ELSEVIER SCIENCE INCOncologyRespiratory System1556-1380